Nothing Special   »   [go: up one dir, main page]
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

Molecular Psychiatry volume 7, pages 515–518 (2002)Cite this article

Abstract

To examine the cannabinoid hypothesis for pathogenesis of schizophrenia, we examined two kinds of polymorphisms of the CNR1 gene, which encodes human CB1 receptor, a subclass of central cannabinoid receptors, in schizophrenics and age-matched controls in the Japanese population. Allelic and genotypic distributions of polymorphism 1359G/A at codon 453 in the coding region and AAT triplet repeats in the 3′ flanking region in the Japanese population were quite different from those in Caucasians. Although the polymorphism 1359G/A was not associated with schizophrenia, the triplet repeat polymorphism of the CNR1 gene was significantly associated with schizophrenia, especially the hebephrenic subtype (P = 0.0028). Hebephrenic schizophrenia showed significantly increased rate of the 9 repeat allele (P = 0.032, OR = 2.30, 95% CI (1.91–2.69)), and decreased rate of the 17 repeat allele (P = 0.011, OR = 0.208, 95% CI (0.098–0.439)). The present findings indicated that certain alleles or genotypes of the CNR1 gene may confer a susceptibility of schizophrenia, especially of the hebephrenic type.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Halikas JA, Goodwin DW, Guze SB . Marihuana use and psychiatric illness Arch Gen Psychiatry 1972 27: 162–165

    Article  CAS  Google Scholar 

  2. Spencer DJ . Cannabis-induced psychosis Int J Addict 1971 6: 323–326

    Article  CAS  Google Scholar 

  3. Johns A . Psychiatric effects of cannabis Br J Psychiatry 2001 178: 116–122

    Article  CAS  Google Scholar 

  4. McGuire PK, Jones P, Harvey I, Bebbington P, Toone B, Lewis S et al. Cannabis and acute psychosis Schizophr Res 1994 13: 161–167

    Article  CAS  Google Scholar 

  5. Negrete JC . Cannabis and schizophrenia Br J Addict 1989 84: 349–351

    Article  CAS  Google Scholar 

  6. Turner WM, Tsuang MT . Impact of substance abuse on the course and outcome of schizophrenia Schizophr Bull 1990 16: 87–95

    Article  CAS  Google Scholar 

  7. Treffert DA . Marijuana use in schizophrenia: a clear hazard Am J Psychiatry 1978 135: 1213–1215

    Article  CAS  Google Scholar 

  8. Breakey WR, Goodell H, Lorenz PC, McHugh PR . Hallucinogenic drugs as precipitants of schizophrenia Psychol Med 1974 4: 255–261

    Article  CAS  Google Scholar 

  9. Hollister LE . Health aspects of cannabis Pharmacol Rev 1986 38: 1–20

    CAS  PubMed  Google Scholar 

  10. Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR . Cannabis consumption as a prognostic factor in schizophrenia Br J Psychiatry 1994 164: 679–681

    Article  CAS  Google Scholar 

  11. Liskow B . Marihuana deterioration Jama 1970 214: 1709

    Article  CAS  Google Scholar 

  12. Andreasson S, Allebeck P, Engstrom A, Rydberg U . Cannabis and schizophrenia. A longitudinal study of Swedish conscripts Lancet 1987 2: 1483–1486

    Article  CAS  Google Scholar 

  13. Emrich HM, Leweke FM, Schneider U . Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system Pharmacol Biochem Behav 1997 56: 803–807

    Article  CAS  Google Scholar 

  14. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC . Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 1988 34: 605–613

    CAS  Google Scholar 

  15. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC . Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 1991 11: 563–583

    Article  CAS  Google Scholar 

  16. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al. Cannabinoid receptor localization in brain Proc Natl Acad Sci USA 1990 87: 1932–1936

    Article  CAS  Google Scholar 

  17. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI . Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 1990 346: 561–564

    Article  CAS  Google Scholar 

  18. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees Genomics 1997 43: 1–8

    Article  CAS  Google Scholar 

  19. Gadzicki D, Muller-Vahl K, Stuhrmann M . A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene Mol Cell Probes 1999 13: 321–323

    Article  CAS  Google Scholar 

  20. Dawson E . Identification of a polymorphic triplet marker for the brain cannabinoid receptor gene: use in linkage and association studies of schizophrenia Psychiatric Genet 1995 5: S50–S51

    Article  Google Scholar 

  21. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G et al. Cannabinoid receptor gene (CNR1): association with i.v. drug use Mol Psychiatry 1997 2: 161–168

    Article  CAS  Google Scholar 

  22. Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM et al. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population Mol Psychiatry 2000 5: 128–130

    Article  Google Scholar 

  23. Tsai SJ, Wang YC, Hong CJ . Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia Psychiatr Genet 2000 10: 149–151

    Article  CAS  Google Scholar 

  24. Hollister LE . Cannabis—1988 Acta Psychiatr Scand Suppl 1988 345: 108–118

    CAS  PubMed  Google Scholar 

  25. Thomas H . Psychiatric symptoms in cannabis users Br J Psychiatry 1993 163: 141–149

    Article  CAS  Google Scholar 

  26. Mathers DC, Ghodse AH . Cannabis and psychotic illness Br J Psychiatry 1992 161: 648–653

    Article  CAS  Google Scholar 

  27. McGlothlin WH, West LJ . The marihuana problem: an overview Am J Psychiatry 1968 125: 126–134

    Article  CAS  Google Scholar 

  28. Smith D . Acute and chronic toxicity of marijuana J Psychedelic Drugs 1968 2: 37–47

    Article  Google Scholar 

  29. Halikas JA, Goodwin DW, Guze SB . Marihuana effects. A survey of regular users Jama 1971 217: 692–694

    Article  CAS  Google Scholar 

  30. Kupfer DJ, Detre T, Koral J, Fajans P . A comment on the ‘amotivational syndrome’ in marijuana smokers Am J Psychiatry 1973 130: 1319–1322

    Article  CAS  Google Scholar 

  31. Hollister LE . Health aspects of cannabis: revisited Int J Neuropsychopharmacol 1998 1: 71–80

    Article  CAS  Google Scholar 

  32. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 1999 283: 401–404

    Article  CAS  Google Scholar 

  33. Di Marzo V, Melck D, Bisogno T, De Petrocellis L . Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action Trends Neurosci 1998 21: 521–528

    Article  CAS  Google Scholar 

  34. Dean B, Sundram S, Bradbury R, Scarr E, Copolov D . Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use Neuroscience 2001 103: 9–15

    Article  CAS  Google Scholar 

  35. Bacanu SA, Devlin B, Roeder K . The power of genomic control Am J Hum Genet 2000 66: 1933–1944

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Dr Donn R Muhleman (Department of Medical Genetics, City of Hope, National Medical Center and Beckman Research Institute, USA) for providing sequence information on the CNR1 triplet repeats, and to Zikei Institute of Psychiatry (Okayama, Japan) for support in part by a grant.

Author information

Authors and Affiliations

  1. Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan

    H Ujike, M Takaki, K Nakata, Y Tanaka & S Kuroda

  2. Zikei Hospital, Okayama, Japan

    K Nakata & T Takeda

  3. Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA

    Y Tanaka

  4. Takami Hospital, Okayama, Japan

    M Kodama

  5. Takaoka Hospital, Himeji, Japan

    Y Fujiwara

  6. Kasaoka Hospital, Kasaoka, Japan

    A Sakai

Authors
  1. H Ujike
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Takaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Nakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Kodama
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H Ujike.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ujike, H., Takaki, M., Nakata, K. et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 7, 515–518 (2002). https://doi.org/10.1038/sj.mp.4001029

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001029

Keywords

This article is cited by

Search

Advanced search

Quick links